Jesper Hoeiland
CIK 1711694 · President and CEO · last filed 2026-05-11
Jesper Hoeiland is a President and CEO who has filed 12 SEC Form 4 insider transactions across 3 companies since 2017. The most recent filing, for ALLR, was dated May 11, 2026. Across all open-market trades the lifetime net is +$397.1K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $35.8K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$35.8K
3
12
$397.1K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ALLR | Director | 25,000 | $1.43 | $35.8K | $0 | 1 | 2026-05-11 |
| CONCERT PHARMACEUTICALS, INC. (CNCE) Delisted | Director | 0 | $8.37 | $0 | $0 | 5 | 2023-03-06 |
| Radius Health, Inc. (RDUS) Delisted | President and CEO | 12,900 | $30.00 | $387.0K | $397.1K | 6 | 2020-02-24 |
Recent Filings
12 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-11 | ALLR | Grant (A) | +25,000 | $0 | EDGAR |
| 2023-03-06 | CONCERT PHARMACEUTICALS, INC. (CNCE) Delisted | Mixed | −21,525 | $0 | EDGAR |
| 2022-06-13 | CONCERT PHARMACEUTICALS, INC. (CNCE) Delisted | Grant (A) | +16,400 | $0 | EDGAR |
| 2021-06-11 | CONCERT PHARMACEUTICALS, INC. (CNCE) Delisted | Grant (A) | +5,125 | $0 | EDGAR |
| 2020-06-12 | CONCERT PHARMACEUTICALS, INC. (CNCE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-02-24 | Radius Health, Inc. (RDUS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-06-17 | CONCERT PHARMACEUTICALS, INC. (CNCE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-02-26 | Radius Health, Inc. (RDUS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-02-15 | Radius Health, Inc. (RDUS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-11-07 | Radius Health, Inc. (RDUS) Delisted | Buy (P) | +6,800 | $197.5K | EDGAR |